Jump Financial’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,062
Closed -$33.9K 2136
2025
Q4
$33.9K Buy
+10,062
New +$26.1K ﹤0.01% 1880
2024
Q4
Sell
-66,189
Closed -$273K 1820
2024
Q3
$273K Buy
+66,189
New +$356K 0.01% 1351
2024
Q1
Sell
-33,963
Closed -$389K 2083
2023
Q4
$389K Buy
+33,963
New +$336K 0.01% 1199
2023
Q3
Sell
-15,989
Closed -$170K 2040
2023
Q2
$170K Sell
15,989
-78,184
-83% -$840K 0.01% 1549
2023
Q1
$991K Sell
94,173
-24,791
-21% -$278K 0.04% 602
2022
Q4
$1.47M Buy
118,964
+104,220
+707% +$1.18M 0.08% 338
2022
Q3
$153K Buy
+14,744
New +$167K 0.01% 1394
2022
Q2
Sell
-92,587
Closed -$1.16M 1810
2022
Q1
$1.16M Buy
+92,587
New +$1.06M 0.05% 470
2021
Q4
Sell
-71,800
Closed -$938K 1547
2021
Q3
$938K Sell
71,800
-134,500
-65% -$1.74M 0.07% 305
2021
Q2
$2.65M Buy
206,300
+185,300
+882% +$2.12M 0.26% 58
2021
Q1
$235K Buy
+21,000
New +$222K 0.02% 710

Other funds holding IRWD

Jump Financial's IRWD Position: Q1 2026 in Review

Jump Financial sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2026, closing a stake of 10,062 shares — an estimated $33.9K sold.

Jump Financial first reported a position in IRWD in Q1 2021 and held it in 11 quarters. The position peaked at $2.65M in Q2 2021. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Jump Financial reported no remaining Ironwood Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 10,062 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $33.9K.
  • Jump Financial first reported a position in Ironwood Pharmaceuticals in Q1 2021 and held it in 11 quarters.
  • Jump Financial's Ironwood Pharmaceuticals position peaked at $2.65M in Q2 2021.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.